MOACM
BIVV

Mutual of America Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Mutual of America Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-87,259
Closed -$4.71M – 1222
2017
Q4 		$4.71M Sell
87,259
-1,441
-2% -$78.8K 0.07% 409
2017
Q3 		$5.06M Buy
88,700
+612
+0.7% +$35.8K 0.08% 344
2017
Q2 		$5.3M Buy
88,088
+2,183
+3% +$124K 0.09% 308
2017
Q1 		$4.68M Buy
+85,905
New +$4.23M 0.08% 362

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Mutual of America Capital Management's BIVV Position: Q1 2018 in Review

Mutual of America Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 87,259 shares — an estimated $4.71M sold.

Mutual of America Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $5.3M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Mutual of America Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Mutual of America Capital Management sold 87,259 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4.71M.
  • Mutual of America Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Mutual of America Capital Management's Bioverativ Inc. Common Stock position peaked at $5.3M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Mutual of America Capital Management's 13F filing for Q1 2018, filed 11 May 2018.